You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study

Article info

Article menu

Download PDFPDF

Short report
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study

Authors

  • Kadalraja Raghavan Department of Paediatric Neurology, Kenmax Medical Services Pvt. Ltd, Madurai, IndiaDepartment of Paediatric Neurology, Jesuit Antonyraj memorial Inter-disciplinary Centre for Advanced Rehabilitation and Education (JAICARE), Madurai, India PubMed articlesGoogle scholar articles
  • Vidyasagar Devaprasad Dedeepiya Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine, Chennai, India PubMed articlesGoogle scholar articles
  • Nobunao Ikewaki Department of Medical Life Science, Kyushu University of Health and Welfare, Nobeoka, Miyazaki, JapanInstitute of Immunology, Junsei Educational Institute, Nobeoka, Japan PubMed articlesGoogle scholar articles
  • Tohru Sonoda Institute of Immunology, Junsei Educational Institute, Nobeoka, Japan PubMed articlesGoogle scholar articles
  • Masaru Iwasaki Centre for Advancing Clinical Research (CACR), University of Yamanashi Faculty of Medicine Graduate School of Medicine, Chuo, Yamanashi, Japan PubMed articlesGoogle scholar articles
  • Senthilkumar Preethy Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), Chennai, India PubMed articlesGoogle scholar articles
  • Samuel JK Abraham Centre for Advancing Clinical Research (CACR), University of Yamanashi Faculty of Medicine Graduate School of Medicine, Chuo, Yamanashi, JapanAntony- Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co Ltd, Kofu, Yamanashi Prefecture, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Samuel JK Abraham; drsam{at}nichimail.jp
View Full Text

Citation

Raghavan K, Dedeepiya VD, Ikewaki N, et al
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study
BMJ Neurology Open 2022;4:e000203. doi: 10.1136/bmjno-2021-000203

Publication history

  • Accepted December 19, 2021
  • First published January 18, 2022.
Online issue publication 
January 18, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.